For research use only. Not for therapeutic Use.
LCS-1(Cat No.:I030590) is a compound known as a superoxide dismutase 1 (SOD1) inhibitor. It has demonstrated the ability to inhibit the activation of the ERK and PI 3-kinase/AKT signaling pathways induced by serum. By inhibiting SOD1, LCS-1 potentially modulates cellular responses mediated by these signaling pathways. The ERK and PI 3-kinase/AKT pathways play crucial roles in various cellular processes, and their dysregulation has been implicated in several diseases.
Catalog Number | I030590 |
CAS Number | 41931-13-9 |
Synonyms | LCS-1, LCS1, LCS 1 |
Molecular Formula | C11H8Cl2N2O |
Purity | 98% |
Target | Immunology/Inflammation |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | 2-8°C |
IUPAC Name | 4,5-dichloro-2-m-tolylpyridazin-3(2H)-one |
InChI | InChI=1S/C11H8Cl2N2O/c1-7-3-2-4-8(5-7)15-11(16)10(13)9(12)6-14-15/h2-6H,1H3 |
InChIKey | SYUPLLHVMCLXEM-UHFFFAOYSA-N |
SMILES | O=C1C(Cl)=C(Cl)C=NN1C2=CC=CC(C)=C2 |
Reference | 1. R. Somwar et al. Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines. PNAS 2011, 108, 16375-16380. |